SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Camlin Fine Sciences surges on receiving Environmental Clearance for its proposed facility at Gujarat

19 Jul 2016 Evaluate

Camlin Fine Sciences is currently trading at Rs 95.30, up by 3.80 points or 4.15% from its previous closing of Rs. 91.50 on the BSE.

The scrip opened at Rs. 95.00 and has touched a high and low of Rs. 96.50 and Rs. 94.75 respectively. So far 42216 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 121.40 on 03-Nov-2015 and a 52 week low of Rs. 76.10 on 29-Feb-2016.

Last one week high and low of the scrip stood at Rs. 97.80 and Rs. 90.95 respectively. The current market cap of the company is Rs. 980.26 crore.

The promoters holding in the company stood at 39.84%, while Institutions and Non-Institutions held 4.48% and 55.69% respectively.

Camlin Fine Sciences has received Environmental Clearance for its proposed facility at Dahej SEZ, Bharuch District in state of Gujarat. The State Level Environment Impact Assessment Authority, Gujarat at its meeting held on July 16, 2016 has granted the environmental clearance for setting up a manufacturing facility for Hydroquinone/ Catechol and its down-stream products at Dahej SEZ. The said environmental clearance was granted with all the conditions recommended by the State Level Expert Appraisal Committee.

Camlin Fine Chemicals is the world's second largest manufacturer and marketer of food grade antioxidants BHA (butylated hydroxyanisole) and TBHQ (Tertiary Butylhydroquinone).

 

Camlin Fine Sciences Share Price

136.10 5.45 (4.17%)
06-May-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3801.25
Tata Chemicals 816.60
SRF 2719.40
Pidilite Inds. 1421.60
Deepak Nitrite 1821.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×